1[1]Olesen SP,Moller A,Mordvintcev PI, et al. Regional measurements of nitric oxide formed in vivo during brain ischemia. Acta Neurol Scand, 1997 ; 95 (4) : 219
2[2]Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci1997;20(3) :132
3[3]Dobrucki LW, Kalinowski L, Uracz W, et al. The protection role of nitric oxide in the ischemic brain. J Physiol Pharmacol,2000;51(4 Pt1) : 695
4[4]Brune B, Knethen A, Sandau KB. Transcription factors p53 and HIF-1α as targets of nitric oxide. Cell Signal, 2001 ; 13 (8) : 525
5[5]Robertson GS, Crocker SJ, Nicholson DW, et al.Neuroprotection by the inhibition of apoptosis. Brain Pathol,2000;10(2) : 283
6[6]Blumberg RM, Taylor DL, Yue X, et al. Increased nitric oxide synthase involve deleyed cerebral energy failure following focal hypoxic ischemic injury in the developing brain. Pediatr Res, 1999 ; 46 (2) : 224
7[7]Kinouchi H,Kamii H,Mikawa S,et al. Role of super oxide dismutase in ischemic brain injury:a study using SOD transgenic mice. Cell Mol Neurobiol, 1998 ; 18 (6): 609
8[8]Kidd GA, Dobruki LW, Brovkovych V. Nitric oxide deficency contributes to cerebral infarct size.Hypersension,2000;135(5) : 1111
9[9]Nagayama M,Zhang F, Iadecola C. Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats. J Cereb Blood Flow Metab,1998;18(10) : 1107
10[10]Iadecola C, Zhang F, Cusey R,et al. Knockout mice lacking the inducible nitric oxide synthase gene are resistant to cerebral ischemia. Soc Neurosci, 1996; 22: 1693
